Skip to content

KetoEasy meal plan for Ketogenic Diet Therapy in children 2-12 years with parmacoresistant epilepsy

KetoEasy meal plan for Ketogenic Diet Therapy in children 2-12 years with parmacoresistant epilepsy - KetoEasy mealplan

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51530
Enrollment
Unknown
Registered
2022-05-24
Start date
2022-12-06
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pharmacoresistant epilepsy

Interventions

Ketogenic Diet Therapy (KDT) is a specialist medical diet for children with pharmaco resistant (i.e.2-3 anti-epileptic drugs have failed) epilepsy. It is an extremely high fat (71-90 en%), very low

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: -age 2-12 years -seizures inadequately responding to 2-3 anti-epileptic drugs -or experiencing severe side effects on anti-epileptic drugs -or on waiting list for epilepsy surgery -be able to read Dutch language -signed informed consent

Exclusion criteria

Exclusion criteria: -complex medical condition requiring hospitalization for ketogenic diet initiation -age 12 years -KDT used in the past

Design outcomes

Primary

MeasureTime frame
Primary parameter/endpoint Percentage of included patients having ketone levels > 3 mmol/l within4 months after start Ketogenic Diet Therapy by using the KetoEasy mealplan.

Secondary

MeasureTime frame
Secondary study parameters/endpoints - Ketone levels (daily measured) during 4 month study period (median/mean and range mmol/l in blood week 1-5, month 2,3,4 and total study period) - Time to adequate ketosis (in days) after diet initiation - Number and kind of side effects: hyperketosis (>6.5 mmol/l), hypoglycemia (5 mmol/l , triglycerides >3 mmol/l), gastro-intestinal problems (constipation, vomiting, diarrhea), food refusal, weight loss (>5% of baseline weight) -Seizure reduction defined as > 50% seizure reduction 3 months after completing KDT dietinitiation -Number of drop outs and reason for stopping -Feasibility of KDT application by the use of the KetoEasy meal plan user-friendliness, variety and application in daily use by parents. -Nutritional composition of the food intake at baseline, at week 5 and end study (energy, protein, fat and carb) Other study parameters -Feasibility of KDT as use of KetoEasy meal plan during initiation, fine tuning and follow up by the dietitians and medical doctors of the ketoteam.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Apr 17, 2026